InDevR Collaborates with I&L Biosystems to Market Products in Western Europe: Includes Sales & Support for CypherOne & Soon to Launch VaxArray

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

April 4, 2017

InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, is pleased to announce an exclusive sales, marketing, and customer support relationship with I&L Biosystems GmbH and its subsidiaries.

InDevR notes the distribution agreement includes sales and support for the Cypher One™ and soon to launch VaxArray™ product lines throughout Western Europe.

The company manufactures and sells Cypher One™, an automated hemagglutination analyzer used by biopharmaceutical vaccine manufacturers and veterinary diagnostic labs. The Cypher One™ system automates and standardizes HA and HAI analysis and provides a digital, traceable record to enhance data quality and reliability. InDevR is also developing a comprehensive vaccine potency platform called VaxArray™. When fully launched, the VaxArray™ platform will measure both hemagglutinin and neuraminidase content of both seasonal and pandemic influenza. VaxArray™ will enable biopharmaceutical manufacturers the ability to generate consistent potency data throughout upstream and downstream testing and enhance process recovery applications. InDevR’s products support vaccine developers and manufactures by providing faster turnaround times and improved results at an affordable price. More information can be found at: http://indevr.com/products

I&L Biosystems, a European sales and marketing leader, was founded in 1991 and has been growing ever since. With a focus on sales and distribution of high-quality laboratory equipment to customers and researchers in the field of microbiology, cell biology, biotechnology and process control, I&L Biosystems have established themselves as a proven leader. I&L Biosystems is located in Germany and expands its coverage of western European countries through subsidiaries located in the Netherlands, France and UK. I&L Biosystems’ mission complements InDevR’s unique product lines as both are focused on modernizing the field of life science with respect to vaccine development and production.

“I&L Biosystems brings unparalleled knowledge and expertise to our current and future customers. They offer in-country support with a team of native language speakers that really understand the challenges, successes and trends our European customers experience on a day to day basis,” said Dawn Bitz, Chief Commercial Officer of InDevR. “We are excited to reestablish this relationship with a trusted partner.”

“Our long-lasting relationship with InDevR is based on trust, scientific exchange and a fundamental connection. The combination of InDevR’s knowledge and I&L Biosystems’ experience in the European market is grounded in past successes. Now we are proud to introduce InDevR’s newest technologies into Europe with the confidence that InDevR instruments will be an incredible benefit to our customers,” said Dr. Sandra Balkow, Scientific Sales Director of I&L Biosystems GmbH.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.